Teva Pharmaceuticals Reduces Manual QMS Processes by 60% with eQMS Software

Teva Pharmaceuticals is one of the world's largest generic and specialty pharmaceutical companies, with a presence in over 60 countries and a medicine portfolio covering hundreds of conditions. With manufacturing operations spanning multiple continents and thousands of SKUs in production, Teva faced the complexity of managing quality processes across a vast, diverse enterprise — often relying on siloed systems and manual documentation.

AmpleLogic partnered with Teva to implement a comprehensive eQMS platform that unified quality event management, CAPA tracking, deviation handling, and change control across Teva's operations. The platform's configurable workflow engine was tailored to Teva's complex approval hierarchies and site-specific requirements, enabling rapid deployment without sacrificing the flexibility needed for global operations.

The digitization eliminated manual handoffs that previously caused delays and documentation gaps. Real-time dashboards provided quality leaders with instant visibility into open events, pending approvals, and overdue actions across all sites. Automated escalations ensured that critical quality issues received timely attention, and regulatory-compliant audit trails made inspection preparation significantly faster.

Teva achieved a 60% reduction in manual processes within the first year of deployment. Investigation cycle times shortened, right-first-time rates improved, and the organization moved closer to a proactive quality management model — detecting and addressing issues before they could impact product quality or patient safety.